ClinicalTrials.gov record
Not listed Phase 2Phase 3 Interventional

Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00030641

Public ClinicalTrials.gov record NCT00030641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 4:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Study of Docetaxel Versus Docetaxel Plus Genasense™ (G3139; Bcl-2 Antisense Oligonucleotide) in Patients With Previously Treated Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT00030641
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Genta Incorporated
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • docetaxel Drug
  • oblimersen sodium Biological

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2001
Primary completion
Not listed
Completion
Not listed
Last update posted
Jan 5, 2014

Started 2001

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300
Montgomery Cancer Center Montgomery Alabama 36106-2801
Little Rock Hematology-Oncology Associates Little Rock Arkansas 72205
East Bay Medical Oncology Concord California 94520
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095
Medical Oncology Care Associates Orange California 92868
Pacific Hematology/Oncology San Francisco California 94115
John Wayne Cancer Institute at Saint John's Health Center Santa Monica California 90404
University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora Colorado 80010
Whittingham Cancer Center Norwalk Connecticut 06856
Lakeland Regional Cancer Center Lakeland Florida 33805
Georgia Cancer Specialists - Northside Office Atlanta Georgia 30342
Augusta Oncology Associates Augusta Georgia 30901
University of Chicago Cancer Research Center Chicago Illinois 60637
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Central Baptist Hospital Lexington Kentucky 40503
Hematology Oncology Services New Orleans Louisiana 70115
Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana 71130-3932
Josephine Ford Cancer Center at Henry Ford Hospital Detroit Michigan 48202
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha Omaha Nebraska 68114-4199
Summit Medical Group, P.A. Summit New Jersey 07901
Winthrop University Hospital Mineola New York 11501
North General Hospital New York New York 10035
Veterans Affairs Medical Center - Oklahoma City Oklahoma City Oklahoma 73104
Charleston Cancer Center Charleston South Carolina 29406
Arlington Cancer Center Arlington Texas 76012-2510
Medical City Dallas Hospital Dallas Texas 75230
Harold Simmons Cancer Center Dallas Texas 75390-8852
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410-1894
Texas Cancer Care Weatherford Texas 76086
Madigan Army Medical Center Tacoma Washington 98431-5048
Yakima Regional Cancer Care Center Yakima Washington 98902
Morgantown Internal Medicine Group Morgantown West Virginia 26505
West Virginia University Hospitals Morgantown West Virginia 26506-9162

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00030641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 5, 2014 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00030641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →